SCHEMBL20125531

SCHEMBL20125531

CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4ccc(C)c(-c5ccccc5C)c4)[nH]3)cc2)n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.49
KIT P10721 1/20 0.49
PDGFRA P16234 1/20 0.49
CDK11B P21127 1/20 0.49
FLT3 P36888 1/20 0.49
CDKL2 Q92772 1/20 0.49
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
PLA2G7 Q13093 3/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 2/20 0.33
F2 P00734 1/20 0.33
PLG P00747 1/20 0.33
PRSS1 P07477 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSP90AA1 P07900 1/20 0.33
PRMT5 O14744 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626812 0.89 PDGFRB (0.51) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL12336741 0.87 PDGFRB (0.47) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL14949485 0.86 PDGFRB (0.55) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL12336563 0.86 PDGFRB (0.49) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL14949292 0.86 PDGFRB (0.50) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL14949287 0.85 PDGFRB (0.49) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL14949290 0.85 PDGFRB (0.51) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL12336289 0.85 PDGFRB (0.56) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL627644 0.84 PDGFRB (0.50) PDGFRBKITPDGFRACDK11BFLT3
SCHEMBL12348800 0.83 PDGFRB (0.50) PDGFRBKITPDGFRACDK11BFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2550266-B1 HETEROCYCLIC COMPOUNDS USEFUL FOR KINASE INHIBITION AMITECH THERAPEUTICS SOLUTIONS INC (US) 2018-05-09 EP disclosed